A Pilot Study for the Effect of Human Basal Cell Transplantation in the Treatment of Bronchiectasis

A Pilot Study for the Effect of Human Basal Cell Transplantation in the Treatment of Bronchiectasia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017874

Enrollment

Unknown

Registered

2018-08-18

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

Case series:Case series

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Bronchiectasisobvious signs and symptoms of Bronchiectasis; 3. DLCO 2 weeks; 5. Be able to do fiberbronchoscopy; 6. agree to participate the study; 7. Follow-up on regularly.

Exclusion criteria

Exclusion criteria: 1. Women at childbearing age; 2. SyphilisHIVHBVHCV positive; 3. Cancer; 4. Ashmatuberculosispulmonary embolismpneumothoraxPulmonary Hypertension diffuse parenchymal lung disease; 5. other systematic diseases; 6. WBC<4x10^9/L or WBC <1.5x10^9/L or neutrophils <0.5x10^9/L; 7. Severe kidney injury; 8. liver injury; 9. mental disease, epilepsyor other central nervous system diseases; 10. Arhythmia; 11. alcohol addicted; 12. accept other clinical trials in 3 months; 13. unable to complete follow-ups.

Design outcomes

Primary

Measure	Time frame
DLCO;	—

Secondary

Measure	Time frame
lung-function test;6-minute walk test and DSP score;CT scan;SGRQ score;	—

Countries

China

Contacts

Public ContactQU Jieming

Ruijin Hospital affiliated Shanghai Jiao Tong University School of Medicine

jmqu0906@163.com+86 021-64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026